Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-498bnqCompleted
Randomised, open-label trial in chronic rhinitis comparing Mometasone furoate + isotonic nasal saline with Isotonic nasal saline control (2 arms). Primary endpoint: Nasal inspiratory peak flow. Started Mar 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-498bnq.